Communicating risks and benefits about ethically controversial topics: The case of induced pluripotent stem (iPS) cells

Dr. Holly Longstaff and colleagues writes on “Communicating risks and benefits about ethically controversial topics: The case of induced pluripotent stem (iPS) cells” at Stem Cell Reviews and Reports. To read more, click here.